Suzanne Hodgkinson

Associate Professor

 

A/Professor Suzanne Hodgkinson has been working on autoimmune neurological diseases since 1982 and in 1994, her autoimmune research team started working with the transplant research team at Liverpool Hospital in a collaborative way. In 2005, the two groups joined resources to form the Immune Tolerance Laboratory. 

The Immune Tolerance Laboratory conducts research into the cellular and cytokine mechanisms of immune tolerance that occurs in transplantation models, and models of autoimmunity.    We use animal models of inbred rat strains bred in the Liverpool Animal House that are not Specific Pathogen-free (SPF), so the heart grafting and autoimmune experiments are performed to replicate human patients in a hospital and later, a community environment.  We are examining how to modify the body's immune system to accept transplanted organs, to minimise and perhaps eventually eliminate the use of current toxic immunosuppressive regimens, and to alleviate autoimmune disease in patients to provide a better standard of living.  

A/Professor Hodgkinson is the Chief Investigator on a NHMRC grant looking into work on Experimental Autoimmune Encephalomyelitis (EAE) and Experimental Autoimmune Neuritis (EAN), which are animal models of autoimmune neurological disease. EAN is the standard rat model for Guillain Bárre syndrome (GBS), a demyelinating disease of the peripheral nervous system causing partial to complete paralysis.  EAE is the rat model for multiple sclerosis (MS), a demyelinating disease of the central nervous system causing partial to complete paralysis occurring mainly in young adults. We are testing methods of promoting the development of the antigen specific CD4+CD25+Foxp3+ T regulatory cell and then using them to treat the disease.

Currently, chronic rejection of heart transplants is an ongoing issue. In our transplantation model, the focus is on the use of cytokines including late Th1 and Th2 cytokines, which specifically promote antigen specific tolerance towards grafted organs.  We have recently tested this in a model of chronic rejection in the rat and have shown that the use of IL-5 alone can prevent and treat chronic rejection.  At this point, clinically, there is no currently available treatment for chronic rejection. We are further exploring how we can switch on these Tregs so organ transplants can be clinically possible without the need for immunosuppression. 

publications

Journal articles
add
Tran GT; Hodgkinson SJ; Carter N; Verma ND; Robinson CM; Plain KM; Nomura M; Hall BM, 2020, 'Autoantigen specific IL-2 activated CD4+CD25+T regulatory cells inhibit induction of experimental autoimmune neuritis', Journal of Neuroimmunology, vol. 341, http://dx.doi.org/10.1016/j.jneuroim.2020.577186
2020
Bukhari W; Clarke L; O’Gorman C; Khalilidehkordi E; Arnett S; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Ramanathan S; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Dear K; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez-Sanchez S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonnell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt J; Slee M; Taylor BV; Willoughby E; Wilson RJ; Brilot F; Vincent A; Waters P; Broadley SA, 2020, 'The clinical profile of NMOSD in Australia and New Zealand', Journal of Neurology, http://dx.doi.org/10.1007/s00415-020-09716-4
2020
Fambiatos A; Jokubaitis V; Horakova D; Kubala Havrdova E; Trojano M; Prat A; Girard M; Duquette P; Lugaresi A; Izquierdo G; Grand’Maison F; Grammond P; Sola P; Ferraro D; Alroughani R; Terzi M; Hupperts R; Boz C; Lechner-Scott J; Pucci E; Bergamaschi R; Van Pesch V; Ozakbas S; Granella F; Turkoglu R; Iuliano G; Spitaleri D; McCombe P; Solaro C; Slee M; Ampapa R; Soysal A; Petersen T; Sanchez-Menoyo JL; Verheul F; Prevost J; Sidhom Y; Van Wijmeersch B; Vucic S; Cristiano E; Saladino ML; Deri N; Barnett M; Olascoaga J; Moore F; Skibina O; Gray O; Fragoso Y; Yamout B; Shaw C; Singhal B; Shuey N; Hodgkinson S; Altintas A; Al-Harbi T; Csepany T; Taylor B; Hughes J; Jun JK; van der Walt A; Spelman T; Butzkueven H; Kalincik T, 2020, 'Risk of secondary progressive multiple sclerosis: A longitudinal study', Multiple Sclerosis Journal, vol. 26, pp. 79 - 90, http://dx.doi.org/10.1177/1352458519868990
2020
Ledingham D; El-Wahsh S; Sebire D; Cappelen-Smith C; Hodgkinson SJ; McDougall AJ; Maley M; Cordato DJ, 2019, 'Adjuvant immunosuppression for paradoxical deterioration in tuberculous meningitis including one case responsive to cyclosporine. A tertiary referral hospital experience', Journal of the Neurological Sciences, vol. 404, pp. 58 - 62, http://dx.doi.org/10.1016/j.jns.2019.07.002
2019
Bhaskar S; Thomas P; Cheng Q; Clement N; McDougall A; Hodgkinson S; Cordato D, 2019, 'Trends in acute stroke presentations to an emergency department: Implications for specific communities in accessing acute stroke care services', Postgraduate Medical Journal, vol. 95, pp. 258 - 264, http://dx.doi.org/10.1136/postgradmedj-2019-136413
2019
Nguyen AL; Havrdova EK; Horakova D; Izquierdo G; Kalincik T; van der Walt A; Terzi M; Alroughani R; Duquette P; Girard M; Prat A; Boz C; Sola P; Ferraro D; Lugaresi A; Lechner-Scott J; Barnett M; Grand'Maison F; Grammond P; Ramo-Tello C; Turkoglu R; McCombe P; Pucci E; Trojano M; Granella F; Spitaleri D; Van Pesch V; Soysal A; Oreja-Guevara C; Verheul F; Vucic S; Hodgkinson S; Slee M; Ampapa R; Prevost J; Menoyo JLS; Skibina O; Solaro C; Olascoaga J; Shaw C; Madsen KG; Naidoo K; Hyde R; Butzkueven H; Jokubaitis V, 2019, 'Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study', Multiple Sclerosis and Related Disorders, vol. 28, pp. 235 - 243, http://dx.doi.org/10.1016/j.msard.2019.01.003
2019
Bhaskar S; Saab J; Cappelen-Smith C; Killingsworth M; Wu XJ; Cheung A; Manning N; Aouad P; McDougall A; Hodgkinson S; Cordato D, 2019, 'Clot Histopathology in Ischemic Stroke with Infective Endocarditis', Canadian Journal of Neurological Sciences, vol. 46, pp. 331 - 336, http://dx.doi.org/10.1017/cjn.2019.8
2019
Brown JWL; Coles A; Horakova D; Havrdova E; Izquierdo G; Prat A; Girard M; Duquette P; Trojano M; Lugaresi A; Bergamaschi R; Grammond P; Alroughani R; Hupperts R; McCombe P; Van Pesch V; Sola P; Ferraro D; Grand'Maison F; Terzi M; Lechner-Scott J; Flechter S; Slee M; Shaygannejad V; Pucci E; Granella F; Jokubaitis V; Willis M; Rice C; Scolding N; Wilkins A; Pearson OR; Ziemssen T; Hutchinson M; Harding K; Jones J; McGuigan C; Butzkueven H; Kalincik T; Robertson N; Onofrj M; De Luca G; Di Tommaso V; Travaglini D; Pietrolongo E; di Ioia M; Farina D; Mancinelli L; Hodgkinson S; Oreja-Guevara C; Boz C; Prevost J; Olascoaga J; Van Wijmeersch B; Barnett M; Verheul F; Rojas JI; Spitaleri D; Rio ME; Taylor B; Luis Sanchez-Menoyo J; Ramo-Tello C; Solaro C; Csepany T; Iuliano G; Skibina O; Petersen T; Bolanos RF; Sidhom Y; Riadh ; Vucic S; Macdonell R; Sempere AP; Simo M; Kister I; Shuey N; Radek ; Dominguez JA; Pia Amato M; Saladino ML; Kermode A; Butler E; Moore F; Hughes S; McDonnell G; Piroska I; Yamout B; Soysal A; Ozakbas S; Zwanikken C, 2019, 'Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis', JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, vol. 321, pp. 175 - 187, http://dx.doi.org/10.1001/jama.2018.20588
2019
Tea F; Lopez JA; Ramanathan S; Merheb V; Lee FXZ; Zou A; Pilli D; Patrick E; van der Walt A; Monif M; Tantsis EM; Yiu EM; Vucic S; Henderson APD; Fok A; Fraser CL; Lechner-Scott J; Reddel SW; Broadley S; Barnett MH; Brown DA; Lunemann JD; Dale RC; Brilot F; Sinclair A; Kermode AG; Kornberg A; Bye A; McGettigan B; Trewin B; Brew B; Taylor B; Bundell C; Miteff C; Troedson C; Pridmore C; Spooner C; Yiannikas C; O'Gorman C; Clark D; Suan D; Jones D; Kilfoyle D; Gill D; Wakefield D; Hofmann D; Mathey E; O'Grady G; Jones HF; Beadnall H; Butzkueven H; Joshi H; Andrews I; Sutton I; MacIntyre J; Sandbach JM; Freeman J; King J; O'Neill JH; Parratt J; Barton J; Garber J; Ahmad K; Riney K; Buzzard K; Kothur K; Cantrill LC; Menezes MP; Paine MA; Marriot M; Ghadiri M; Boggild M; Lawlor M; Badve M; Ryan M; Aaqib M; Shuey N; Jordan N; Urriola N; Lawn N; White O; McCombe P; Patel R; Leventer R; Webster R; Smith R; Gupta S; Mohammad SS; Pillai S; Hawke S; Simon S; Calvert S; Blum S; Malone S; Hodgkinson S; Nguyen TK; Hardy TA; Kalincik T; Ware T; Fung VSC, 2019, 'Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination', Acta Neuropathologica Communications, vol. 7, http://dx.doi.org/10.1186/s40478-019-0786-3
2019
Kalincik T; Kubala Havrdova E; Horakova D; Izquierdo G; Prat A; Girard M; Duquette P; Grammond P; Onofrj M; Lugaresi A; Ozakbas S; Kappos L; Kuhle J; Terzi M; Lechner-Scott J; Boz C; Grand'maison F; Prevost J; Sola P; Ferraro D; Granella F; Trojano M; Bergamaschi R; Pucci E; Turkoglu R; McCombe PA; Pesch VV; Van Wijmeersch B; Solaro C; Ramo-Tello C; Slee M; Alroughani R; Yamout B; Shaygannejad V; Spitaleri D; Sánchez-Menoyo JL; Ampapa R; Hodgkinson S; Karabudak R; Butler E; Vucic S; Jokubaitis V; Spelman T; Butzkueven H, 2019, 'Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 90, pp. 458 - 468, http://dx.doi.org/10.1136/jnnp-2018-319831
2019
Verma ND; Robinson CM; Carter N; Wilcox P; Tran GT; Wang C; Sharland A; Nomura M; Plain KM; Bishop GA; Hodgkinson SJ; Hall BM, 2019, 'Alloactivation of naïve CD4+ CD8 CD25+T regulatory cells: Expression of CD8α identifies potent suppressor cells that can promote transplant tolerance induction', Frontiers in Immunology, vol. 10, pp. 2397, http://dx.doi.org/10.3389/fimmu.2019.02397
2019
Kappos L; Bar-Or A; Cree BAC; Fox RJ; Giovannoni G; Gold R; Vermersch P; Arnold DL; Arnould S; Scherz T; Wolf C; Wallström E; Dahlke F; Achiron A; Achtnichts L; Agan K; Akman-Demir G; Allen AB; Antel JP; Antiguedad AR; Apperson M; Applebee AM; Ayuso GI; Baba M; Bajenaru O; Balasa R; Balci BP; Barnett M; Bass A; Becker VU; Bejinariu M; Bergh FT; Bergmann A; Bernitsas E; Berthele A; Bhan V; Bischof F; Bjork RJ; Blevins G; Boehringer M; Boerner T; Bonek R; Bowen JD; Bowling A; Boyko AN; Boz C; Bracknies V; Braune S; Brescia Morra V; Brochet B; Brola W; Brownstone PK; Brozman M; Brunet D; Buraga I; Burnett M; Buttmann M; Butzkueven H; Cahill J; Calkwood JC; Camu W; Cascione M; Castelnovo G; Centonze D; Cerqueira J; Chan A; Cimprichova A; Cohan S; Comi G; Conway J; Cooper JA; Corboy J; Correale J; Costell B; Cottrell DA; Coyle PK; Craner M; Cui L; Cunha L; Czlonkowska A; da Silva AM; de Sa J; de Seze J; Debouverie M; Debruyne J; Decoo D; Defer G; Derfuss T; Deri NH; Dihenia B; Dioszeghy P; Donath V; Dubois B; Duddy M; Duquette P; Edan G; Efendi H; Elias S; Emrich PJ; Estruch BC, 2018, 'Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study', The Lancet, vol. 391, pp. 1263 - 1273, http://dx.doi.org/10.1016/S0140-6736(18)30475-6
2018
Venkat A; Cappelen-Smith C; Askar S; Thomas PR; Bhaskar S; Tam A; McDougall AJ; Hodgkinson SJ; Cordato DJ, 2018, 'Factors Associated with Stroke Misdiagnosis in the Emergency Department: A Retrospective Case-Control Study', Neuroepidemiology, pp. 123 - 127, http://dx.doi.org/10.1159/000491635
2018
Kister I; Spelman T; Patti F; Duquette P; Trojano M; Izquierdo G; Lugaresi A; Grammond P; Sola P; Ferraro D; Grand'Maison F; Alroughani R; Terzi M; Boz C; Hupperts R; Lechner-Scott J; Kappos L; Pucci E; Hodgkinson S; Solaro C; Butzkueven H, 2018, 'Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy', Journal of the Neurological Sciences, vol. 391, pp. 72 - 76, http://dx.doi.org/10.1016/j.jns.2018.06.001
2018
Kalincik T; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Lechner-Scott J; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Solaro C; Grand’Maison F; Hupperts R; Prevost J; Sola P; Ferraro D; Terzi M; Butler E; Slee M; Kermode A; Fabis-Pedrini M; McCombe P; Barnett M; Shaw C; Hodgkinson S; Butzkueven H, 2018, 'Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis', Multiple Sclerosis Journal, vol. 24, pp. 1617 - 1626, http://dx.doi.org/10.1177/1352458517728812
2018
Hughes J; Jokubaitis V; Lugaresi A; Hupperts R; Izquierdo G; Prat A; Girard M; Duquette P; Grand'Maison F; Grammond P; Sola P; Ferraro D; Ramo-Tello C; Trojano M; Slee M; Shaygannejad V; Boz C; Lechner-Scott J; Van Pesch V; Pucci E; Solaro C; Verheul F; Terzi M; Granella F; Spitaleri D; Alroughani R; Jun JK; Fambiatos A; Van Der Walt A; Butzkueven H; Kalincik T, 2018, 'Association of Inflammation and Disability Accrual in Patients with Progressive-Onset Multiple Sclerosis', JAMA Neurology, vol. 75, pp. 1407 - 1415, http://dx.doi.org/10.1001/jamaneurol.2018.2109
2018
Hardy TA; Young S; Sy JS; Colley AF; Terwindt GM; Ferrari MD; Hayes MW; Hodgkinson S, 2018, 'Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCLS): A role for neuroinflammation?', Journal of Neurology, Neurosurgery and Psychiatry, vol. 89, http://dx.doi.org/10.1136/jnnp-2017-316142
2018
Nomura M; Hodgkinson SJ; Tran GT; Verma ND; Robinson C; Plain KM; Boyd R; Hall BM, 2017, 'Cytokines affecting CD4+ T regulatory cells in transplant tolerance. II. Interferon gamma (IFN-γ) promotes survival of alloantigen-specific CD4+ T regulatory cells', Transplant Immunology, vol. 42, pp. 24 - 33, http://dx.doi.org/10.1016/j.trim.2017.05.002
2017
Hall BM; Plain KM; Tran GT; Verma ND; Robinson CM; Nomura M; Boyd R; Hodgkinson SJ, 2017, 'Cytokines affecting CD4+ T regulatory cells in transplant tolerance. III. Interleukin-5 (IL-5) promotes survival of alloantigen-specific CD4+ T regulatory cells', Transplant Immunology, vol. 43-44, pp. 33 - 41, http://dx.doi.org/10.1016/j.trim.2017.06.003
2017
Hall BM; Robinson CM; Plain KM; Verma ND; Tran GT; Nomura M; Carter N; Boyd R; Hodgkinson SJ, 2017, 'Changes in reactivity in vitro of CD4+ CD25+ and CD4+ CD25 T Cell subsets in transplant tolerance', Frontiers in Immunology, vol. 8, http://dx.doi.org/10.3389/fimmu.2017.00994
2017
Gonsalvez DG; Tran G; Fletcher JL; Hughes RA; Hodgkinson S; Wood RJ; Yoo SW; De Silva M; Agnes WW; McLean C; Kennedy P; Kilpatrick TJ; Murray SS; Xiao J, 2017, 'A brain-derived neurotrophic factor-based p75NTR peptide mimetic ameliorates experimental autoimmune neuritis induced axonal pathology and demyelination', eNeuro, vol. 4, http://dx.doi.org/10.1523/ENEURO.0142-17.2017
2017
Kalincik T; Manouchehrinia A; Sobisek L; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Izquierdo G; Lugaresi A; Girard M; Prat A; Duquette P; Grammond P; Sola P; Hupperts R; Grand'Maison F; Pucci E; Boz C; Alroughani R; Van Pesch V; Lechner-Scott J; Terzi M; Bergamaschi R; Iuliano G; Granella F; Spitaleri D; Shaygannejad V; Oreja-Guevara C; Slee M; Ampapa R; Verheul F; McCombe P; Olascoaga J; Amato MP; Vucic S; Hodgkinson S; Ramo-Tello C; Flechter S; Cristiano E; Rozsa C; Moore F; Sanchez-Menoyo JL; Saladino ML; Barnett M; Hillert J; Butzkueven H, 2017, 'Towards personalized therapy for multiple sclerosis: Prediction of individual treatment response', Brain, vol. 140, pp. 2426 - 2443, http://dx.doi.org/10.1093/brain/awx185
2017
Kalincik T; Brown JWL; Robertson N; Willis M; Scolding N; Rice CM; Wilkins A; Pearson O; Ziemssen T; Hutchinson M; McGuigan C; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Izquierdo G; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Alroughani R; Pucci E; Sola P; Hupperts R; Lechner-Scott J; Terzi M; Van Pesch V; Rozsa C; Grand'Maison F; Boz C; Granella F; Slee M; Spitaleri D; Olascoaga J; Bergamaschi R; Verheul F; Vucic S; McCombe P; Hodgkinson S; Sanchez-Menoyo JL; Ampapa R; Simo M; Csepany T; Ramo C; Cristiano E; Barnett M; Butzkueven H; Coles A, 2017, 'Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study', The Lancet Neurology, vol. 16, pp. 271 - 281, http://dx.doi.org/10.1016/S1474-4422(17)30007-8
2017
Tran GT; Wilcox PL; Dent LA; Robinson CM; Carter N; Verma ND; Hall BM; Hodgkinson SJ, 2017, 'Interleukin-5 Mediates Parasite-Induced Protection against Experimental Autoimmune Encephalomyelitis: Association with Induction of Antigen-Specific CD4+CD25+ T Regulatory Cells', Frontiers in Immunology, vol. 8, http://dx.doi.org/10.3389/fimmu.2017.01453
2017
Lizak N; Lugaresi A; Alroughani R; Lechner-Scott J; Slee M; Havrdova E; Horakova D; Trojano M; Izquierdo G; Duquette P; Girard M; Prat A; Grammond P; Hupperts R; Grand'Maison F; Sola P; Pucci E; Bergamaschi R; Oreja-Guevara C; Van Pesch V; Ramo C; Spitaleri D; Iuliano G; Boz C; Granella F; Olascoaga J; Verheul F; Rozsa C; Cristiano E; Flechter S; Hodgkinson S; Amato MP; Deri N; Jokubaitis V; Spelman T; Butzkueven H; Kalincik T, 2017, 'Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 88, pp. 196 - 203, http://dx.doi.org/10.1136/jnnp-2016-313976
2017
Bukhari W; Prain KM; Waters P; Woodhall M; O'Gorman CM; Clarke L; Silvestrini RA; Bundell CS; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brown M; Brownlee WJ; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Dear K; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez-Sanchez S; Killpatrick T; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell R; Mason DF; McCombe PA; Pender MP; Pereira JA; Pollard JD; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt JDE; Slee M; Taylor BV; Willoughby E; Wilson RJ; Vincent A; Broadley SA, 2017, 'Incidence and prevalence of NMOSD in Australia and New Zealand', Journal of Neurology, Neurosurgery and Psychiatry, vol. 88, pp. 632 - 638, http://dx.doi.org/10.1136/jnnp-2016-314839
2017
Stam AH; Kothari PH; Shaikh A; Gschwendter A; Jen JC; Hodgkinson S; Hardy TA; Hayes M; Kempster PA; Kotschet KE; Bajema IM; Van Duinen SG; Maat-Schieman MLC; De Jong PTVM; De Smet MD; De Wolff-Rouendaal D; Dijkman G; Pelzer N; Kolar GR; Schmidt RE; Lacey JA; Joseph D; Fintak DR; Grand MG; Brunt EM; Liapis H; Hajj-Ali RA; Kruit MC; Van Buchem MA; Dichgans M; Frants RR; Van Den Maagdenberg AMJM; Haan J; Baloh RW; Atkinson JP; Terwindt GM; Ferrari MD, 2016, 'Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations', Brain, vol. 139, pp. 2909 - 2922, http://dx.doi.org/10.1093/brain/aww217
2016
Jokubaitis VG; Spelman T; Kalincik T; Lorscheider J; Havrdova E; Horakova D; Duquette P; Girard M; Prat A; Izquierdo G; Grammond P; Van Pesch V; Pucci E; Grand'Maison F; Hupperts R; Granella F; Sola P; Bergamaschi R; Iuliano G; Spitaleri D; Boz C; Hodgkinson S; Olascoaga J; Verheul F; McCombe P; Petersen T; Rozsa C; Lechner-Scott J; Saladino ML; Farina D; Iaffaldano P; Paolicelli D; Butzkueven H; Lugaresi A; Trojano M, 2016, 'Predictors of long-term disability accrual in relapse-onset multiple sclerosis', Annals of Neurology, vol. 80, pp. 89 - 100, http://dx.doi.org/10.1002/ana.24682
2016
Tao C; Simpson S; Van Der Mei I; Blizzard L; Havrdova E; Horakova D; Shaygannejad V; Lugaresi A; Izquierdo G; Trojano M; Duquette P; Girard M; Grand'Maison F; Grammond P; Alroughani R; Terzi M; Oreja-Guevara C; Sajedi SA; Iuliano G; Sola P; Lechner-Scott J; Van Pesch V; Pucci E; Bergamaschi R; Barnett M; Ramo C; Singhal B; Spitaleri DLA; Slee M; Verheul F; Fernández Bolaños R; Amato MP; Cristiano E; Granella F; Hodgkinson S; Fiol M; Gray O; McCombe P; Saladino ML; Sánchez Menoyo JL; Shuey N; Vucic S; Shaw C; Deri N; Arruda WO; Butzkueven H; Spelman T; Taylor BV, 2016, 'Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 87, pp. 1343 - 1349, http://dx.doi.org/10.1136/jnnp-2016-314013
2016
Lorscheider J; Buzzard K; Jokubaitis V; Spelman T; Havrdova E; Horakova D; Trojano M; Izquierdo G; Girard M; Duquette P; Prat A; Lugaresi A; Grand'maison F; Grammond P; Hupperts R; Alroughani R; Sola P; Boz C; Pucci E; Lechner-Scott J; Bergamaschi R; Oreja-Guevara C; Iuliano G; Van Pesch V; Granella F; Ramo-Tello C; Spitaleri D; Petersen T; Slee M; Verheul F; Ampapa R; Amato MP; Mccombe P; Vucic S; Sánchez Menoyo JL; Cristiano E; Barnett MH; Hodgkinson S; Olascoaga J; Saladino ML; Gray O; Shaw C; Moore F; Butzkueven H; Kalincik T, 2016, 'Defining secondary progressive multiple sclerosis', Brain, vol. 139, pp. 2395 - 2405, http://dx.doi.org/10.1093/brain/aww173
2016
Spelman T; Mekhael L; Burke T; Butzkueven H; Hodgkinson S; Havrdova E; Horakova D; Duquette P; Izquierdo G; Grand'Maison F; Grammond P; Barnett M; Lechner-Scott J; Alroughani R; Trojano M; Lugaresi A; Granella F; Pucci E; Vucic S, 2016, 'Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis', European Journal of Neurology, vol. 23, pp. 729 - 736, http://dx.doi.org/10.1111/ene.12929
2016
Hall BM; Tran GT; Robinson CM; Hodgkinson SJ, 2015, 'Induction of antigen specific CD4+CD25+Foxp3+T regulatory cells from naïve natural thymic derived T regulatory cells', International Immunopharmacology, vol. 28, pp. 875 - 886, http://dx.doi.org/10.1016/j.intimp.2015.03.049
2015
Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ, 2015, 'Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab', Journal of Clinical Neuroscience, vol. 22, pp. 598 - 600, http://dx.doi.org/10.1016/j.jocn.2014.08.016
2015
He A; Spelman T; Jokubaitis V; Havrdova E; Horakova D; Trojano M; Lugaresi A; Izquierdo G; Grammond P; Duquette P; Girard M; Pucci E; Iuliano G; Alroughani R; Oreja-Guevara C; Fernandez-Bolaños R; Grand'Maison F; Sola P; Spitaleri D; Granella F; Terzi M; Lechner-Scott J; Van Pesch V; Hupperts R; Sánchez-Menoyo JL; Hodgkinson S; Rozsa C; Verheul F; Butzkueven H; Kalincik T; Giuliani G; Cartechini E; Rio ME; Zwanikken C; Flechter S; Kasa K; Amato MP; Shaygannejad V; Bergamaschi R; Slee M; Boz C; Moore F; Barnett M; Vucic S; McCombe P; Cabrera-Gomez JA; Petersen T; Ramo C; Roullet E; Den Braber-Moerland L; Paolicelli D; Iaffaldano P; Direnzo V; D'Onghia M; Piroska I; Erdelyi T; Iljicsov A; Kovacs K; Sas A; Skibina O; Haartsen J; van Munster E; Fiol M; Correale J; Ysrraelit C; Herbert J; Kister I; Sirbu CA; Shaw C; Vetere S; Petkovska-Boskova T; Singhal B; Bacile EA; Arruda WO; Roger E; Despault P; Marriott M; Van der Walt A; King J; Byron J; Morgan L; Hinson E; De Luca G; Di Tommaso V; Travaglini D; Pietrolongo E; di Ioia M; Farina D; Mancinelli L; Rojas JI; Patrucco L; Williams D; Dark L; Savino A; Chapman J; Cristiano E; Saladino ML; Deri N; Gray O; Hughes S, 2015, 'Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis', JAMA Neurology, vol. 72, pp. 405 - 413, http://dx.doi.org/10.1001/jamaneurol.2014.4147
2015
Mackay AM; Buckingham R; Schwartz RS; Hodgkinson S; Beran RG; Cordato DJ, 2015, 'The Effect of Biofeedback as a Psychological Intervention in Multiple Sclerosis: A Randomized Controlled Study', International Journal of MS Care, vol. 17, pp. 141010081652001 - 141010081652001, http://dx.doi.org/10.7224/1537-2073.2014-006
2015
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies JM; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2015, 'A new era in the treatment of multiple sclerosis', Medical Journal of Australia, vol. 203, pp. 139 - 141, http://dx.doi.org/10.5694/mja14.01218
2015
Kalincik T; Horakova D; Spelman T; Jokubaitis V; Trojano M; Lugaresi A; Izquierdo G; Rozsa C; Grammond P; Alroughani R; Duquette P; Girard M; Pucci E; Lechner-Scott J; Slee M; Fernandez-Bolanos R; Grand'Maison F; Hupperts R; Verheul F; Hodgkinson S; Oreja-Guevara C; Spitaleri D; Barnett M; Terzi M; Bergamaschi R; McCombe P; Sanchez-Menoyo J; Simo M; Csepany T; Rum G; Boz C; Havrdova E; Butzkueven H, 2015, 'Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis', Annals of Neurology, vol. 77, pp. 425 - 435, http://dx.doi.org/10.1002/ana.24339
2015
Arguedas D; Stewart J; Hodgkinson S; Batchelor J, 2015, 'A neuropsychological comparison of siblings with neurological versus hepatic symptoms of Wilson’s Disease', Neurocase, vol. 21, pp. 154 - 161, http://dx.doi.org/10.1080/13554794.2013.878726
2015
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations', Journal of Clinical Neuroscience, vol. 21, pp. 1857 - 1865, http://dx.doi.org/10.1016/j.jocn.2014.01.017
2014
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies', Journal of Clinical Neuroscience, vol. 21, pp. 1835 - 1846, http://dx.doi.org/10.1016/j.jocn.2014.01.016
2014
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy', Journal of Clinical Neuroscience, vol. 21, pp. 1847 - 1856, http://dx.doi.org/10.1016/j.jocn.2014.01.018
2014
Jokubaitis VG; Li V; Kalincik T; Izquierdo G; Hodgkinson S; Alroughani R; Lechner-Scott J; Lugaresi A; Duquette P; Girard M; Barnett M; Grand'Maison F; Trojano M; Slee M; Giuliani G; Shaw C; Boz C; Spitaleri DLA; Verheul F; Haartsen J; Liew D; Butzkueven H, 2014, 'Fingolimod after natalizumab and the risk of short-term relapse', Neurology, vol. 82, pp. 1204 - 1211, http://dx.doi.org/10.1212/WNL.0000000000000283
2014
Verma ND; Hall BM; Plain KM; Robinson CM; Boyd R; Tran GT; Wang C; Bishop GA; Hodgkinson SJ, 2014, 'Interleukin-12 (IL-12p70) promotes induction of highly potent Th1-like CD4+CD25+ T regulatory cells that inhibit allograft rejection in unmodified recipients', Frontiers in Immunology, vol. 5, http://dx.doi.org/10.3389/fimmu.2014.00190
2014
Rege S; Hodgkinson SJ, 2014, 'Anti-neuronal antibodies associated with a first episode of mania', Australian and New Zealand Journal of Psychiatry, vol. 48, pp. 775 - 777, http://dx.doi.org/10.1177/0004867414536934
2014
Rege S; Hodgkinson SJ, 2013, 'Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application', Australian and New Zealand Journal of Psychiatry, vol. 47, pp. 1136 - 1151, http://dx.doi.org/10.1177/0004867413499077
2013
Cordato DJ; Djekic ; Taneja SR; Maley M; Beran RG; Cappelen-Smith C; Griffith N; Hanna IY; Hodgkinson SJ; Worthington JM; Mcdougall AJ, 2013, 'Prevalence of positive syphilis serology and meningovascular neurosyphilis in patients admitted with stroke and TIA from a culturally diverse population (2005–09)', Journal of Clinical Neuroscience, vol. 20, pp. 943 - 947, http://dx.doi.org/10.1016/j.jocn.2012.08.011
2013
Hall BM; Tran GT; Verma ND; Plain KM; Robinson CM; Nomura M; Hodgkinson SJ, 2013, 'Do natural T regulatory cells become activated to antigen specific T regulatory cells in transplantation and in autoimmunity?', Frontiers in Immunology, vol. 4, http://dx.doi.org/10.3389/fimmu.2013.00208
2013
Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM, 2013, 'Cytokines affecting CD4+ T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4+CD25+ Treg', Transplant Immunology, vol. 29, pp. 51 - 59, http://dx.doi.org/10.1016/j.trim.2013.10.003
2013
Ghia D; Thomas PC; Cordato DJ; Epstein D; Beran RG; Cappelen-Smith C; Griffith N; Hanna I; Mcdougall AJ; Hodgkinson SJ; Worthington JM, 2012, 'Low positive predictive value of the ABCD2 score in Emergency Department TIA diagnoses - South West Sydney (SWS) TIA Study', Internal Medicine Journal, vol. 42, pp. 913 - 918, http://dx.doi.org/10.1111/j.1445-5994.2011.02564.x
2012
Lu B; Roussel JC; Murray-Segal L; Salvaris E; Hodgkinson SJ; Hall BM; D'apice AJFF; Cowan P; Gock H, 2012, 'Protective effects of transgenic human endothelial protein C receptor expression in murine models of transplantation', American Journal of Transplantation, vol. 12, pp. 2363 - 2372, http://dx.doi.org/10.1111/j.1600-6143.2012.04122.x
2012
Tran GT; Hodgkinson SJ; Carter N; Verma ND; Plain KM; Boyd RA; Robinson C; Nomura M; Killingsworth MC; Hall BM, 2012, 'IL-5 promotes induction of antigen-specific CD4 +CD25 + T regulatory cells that suppress autoimmunity', Blood, vol. 119, pp. 4441 - 4450, http://dx.doi.org/10.1182/blood-2011-12-396101
2012
Hall BM; Verma ND; Tran GT; Hodgkinson SJ, 2011, 'Distinct regulatory CD4+T cell subsets; differences between naı ̈ve and antigen specific T regulatory cells', Current Opinion in Immunology, vol. 23, pp. 641 - 647, http://dx.doi.org/10.1016/j.coi.2011.07.012
2011
Tran T; Hodgkinson S; Carter N; Verma N; Plain K; Nomura M; Robinson C; Killingsworth M; Boyd R; Hall B, 2011, 'Antigen specific CD4+CD25+Tregs promoted by IL-5 and IL-4 prevented demyelination', MULTIPLE SCLEROSIS JOURNAL, vol. 17, pp. S430 - S430, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209137301318&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Tran G; Hodgkinson S; Carter N; Verma N; Robinson C; Plain K; Boyd R; Hall B, 2011, 'Induction of antigen specific CD4+CD25+T regulatory cells in vitro that control demyelination in autoimmune disease', MULTIPLE SCLEROSIS JOURNAL, vol. 17, pp. S205 - S205, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209137300412&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Wang C; Szun szun T; Tran GT; Hodgkinson SJ; Allen R; Hall BM; Mccaughan GW; Sharland A; Bishop A, 2010, 'Donor IL-4-treatment induces alternatively activated liver macrophages and IDO-expressing NK cells and promotes rat liver allograft acceptance', Transplant Immunology, vol. 22, pp. 172 - 178, http://dx.doi.org/10.1016/j.trim.2009.11.005
2010
Tran GT; Hodgkinson SJ; Carter N; Killingsworth MC; Nomura M; Verma ND; Plain KM; Boyd RA; Hall BM, 2010, 'Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis', Journal of Neuroimmunology, vol. 229, pp. 98 - 106, http://dx.doi.org/10.1016/j.jneuroim.2010.07.010
2010
Ghia D; Thomas P; Cordato DJ; Worthington JM; Cappelen-Smith C; Griffith N; Hanna IY; Hodgkinson SJ; Mcdougall AJ; Beran RG, 2010, 'Validation of Emergency and Final Diagnosis Coding in Transient Ischemic Attack: South Western Sydney Transient Ischemic Attack Study', Neuroepidemiology, vol. 35, pp. 53 - 58, http://dx.doi.org/10.1159/000310338
2010
Hall BM; Tran GT; Hodgkinson SJ, 2009, 'Alloantigen specific T regulatory cells in transplant tolerance', International Immunopharmacology, vol. 9, pp. 570 - 574, http://dx.doi.org/10.1016/j.intimp.2009.01.016
2009
Brown RF; Valpiani EM; Tennant CC; Dunn SM; Sharrock M; Hodgkinson S; Pollard JD, 2009, 'Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis', Psychology and Psychotherapy: Theory, Research and Practice, vol. 82, pp. 41 - 56, http://dx.doi.org/10.1348/147608308X345614
2009
Cordato DJ; Thomas PC; Ghia D; Taneja S; Worthington JM; Mcdougall AJ; Hodgkinson SJ; Hanna IY; Griffith N; Cappelen-Smith C; Beran RG, 2009, 'Decreasing presentations of seizures to emergency departments in a large Australian population', Epilepsy and Behavior, vol. 16, pp. 475 - 478, http://dx.doi.org/10.1016/j.yebeh.2009.08.027
2009
Verma ND; Plain KM; Nomura M; Tran GT; Boyd RA; Hodgkinson SJ; Hall BM; Robinson C, 2009, 'CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses', Blood, vol. 113, pp. 479 - 487, http://dx.doi.org/10.1182/blood-2008-05-156612
2009
Lam V; Taylor CF; Laurence JM; Wang C; Sharland A; McCaughan G; Hodgkinson SJ; Allen R; Hall BM; Bishop A, 2008, 'Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: Effect on foxp3 and cytokine expression and graft infiltration', Transplant Immunology, vol. 19, pp. 20 - 24, http://dx.doi.org/10.1016/j.trim.2008.01.002
2008
Kehdi E; Cordato DJ; Thomas P; Beran RG; Cappelen-Smith C; Griffith N; Hanna I; Mcdougall AJ; Worthington JM; Hodgkinson SJ, 2008, 'Outcomes of patients with transient ischaemic attack after hospital admission or discharge from the emergency department', Medical Journal of Australia, vol. 189, pp. 9 - 12
2008
Hall BM; Robinson C; Plain KM; Verma ND; Carter N; Boyd RA; Tran GT; Hodgkinson SJ, 2008, 'Studies on naive CD4(+) CD25(+) T cells inhibition of naive CD4(+) CD25(-)T cells in mixed lymphocyte cultures', Transplant Immunology, vol. 18, pp. 291 - 301, http://dx.doi.org/10.1016/j.trim.2007.09.002
2008
Richards A; Van Den Maagdenberg AMJM; Jen JC; Kavanagh D; Bertram P; Spitzer D; Liszewski MK; Barilla-Labarca ML; Terwindt GM; Kasai Y; McLellan M; Grand MG; Vanmolkot KRJ; De Vries B; Wan J; Kane MJ; Mamsa H; Schäfer R; Stam AH; Haan J; De Jong PTVM; Storimans CW; Van Schooneveld MJ; Oosterhuis JA; Gschwendter A; Dichgans M; Kotschet KE; Hodgkinson S; Hardy TA; Delatycki MB; Hajj-Ali RA; Kothari PH; Nelson SF; Frants RR; Baloh RW; Ferrari MD; Atkinson JP, 2007, 'C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy', Nature Genetics, vol. 39, pp. 1068 - 1070, http://dx.doi.org/10.1038/ng2082
2007
Davidson C; Verma ND; Robinson C; Plain KM; Tran GT; Hodgkinson SJ; Hall BM, 2007, 'IL-13 prolongs allograft survival: Association with inhibition of macrophage cytokine activation', Transplant Immunology, vol. 17, pp. 178 - 186, http://dx.doi.org/10.1016/j.trim.2006.09.035
2007
Plain KM; Boyd RA; Verma ND; Robinson C; Tran GT; Hodgkinson SJ; Hall BM, 2007, 'Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration', Transplantation, vol. 83, pp. 764 - 773, http://dx.doi.org/10.1097/01.tp.0000256326.11647.2e
2007
Hall BM; Plain KM; Verma ND; Tran GT; Boyd RA; Robinson C; Nicolls M; Berger M; Nomura M; Hodgkinson SJ, 2007, 'Transfer of allograft specific tolerance requires CD4(+)CD25(+)T cells but not interleukin-4 or transforming growth factor-beta and cannot induce tolerance to linked antigens', Transplantation, vol. 83, pp. 1075 - 1084, http://dx.doi.org/10.1097/01.tp.0000259553.66185.2f
2007
Spicer ST; Tran GT; Killingsworth MC; Carter N; Power D; Paizis K; Boyd RA; Hodgkinson SJ; Hall BM, 2007, 'Induction of passive Heymann nephritis in complement component 6-deficient PVG rats', Journal of Immunology, vol. 179, pp. 172 - 178, http://dx.doi.org/10.4049/jimmunol.179.1.172
2007
Hodgkinson SJ; Tran GT; Carter N; Killingsworth MC, 2006, 'Membrane attack complex is not required for demyelination in experimental allergic neuritis', Multiple Sclerosis, vol. 12, pp. S50 - S50, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241921400163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2006
Nomura M; Plain KM; Verma ND; Robinson C; Boyd RA; Hodgkinson SJ; Hall BM, 2006, 'The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells / CD4+CD25− T cells determines rejection or tolerance', Transplant Immunology, vol. 15, pp. 311 - 318, http://dx.doi.org/10.1016/j.trim.2006.01.003
2006
Hodgkinson SJ; Sedal L; Paine M; Siejka S; Gorai D; Butzkueven H; Willoughby E; Boundy KL; Booth D; Mackay F; Tabensky A; Sartori L; Curnow K, 2006, 'Developing strategies to manage neutralising antibodies - preliminary results from the RENeu study', Multiple Sclerosis, vol. 12, pp. S203 - S204, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241921400668&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2006
Brown RF; Tennant CC; Sharrock M; Hodgkinson SJ; Dunn SM; Pollard JD, 2006, 'Relationship between stress and relapse in multiple sclerosis: part II Direct and indirect relationships.', Multiple Sclerosis, vol. 12, pp. 465 - 475, http://dx.doi.org/10.1191/1352458506ms1296oa
2006
Brown RF; Tennant CC; Sharrock M; Hodgkinson SJ; Dunn SM; Pollard JD, 2006, 'Relationship between stress and relapse in multiple sclerosis:Part 1. Important features', Multiple Sclerosis, vol. 12, pp. 453 - 464, http://dx.doi.org/10.1191/1352458506ms1295oa
2006
Wang C; Li J; Cordoba S; McLeod D; Tran GT; Hodgkinson SJ; Hall BM; Mccaughan GW; Bishop G, 2005, 'Posttransplant interleukin-4 treatment converts rat liver allograft tolerance to rejection', Transplantation, vol. 79, pp. 1116 - 1120, http://dx.doi.org/10.1097/01.TP.0000161249.20922.16
2005
Levi CR; Blacker DJ; Bladin CF; Boers PM; Chambers BR; Chu LL; Corbett AJ; Crimmins DS; Davis SM; Donnan GA; Dunbabin DW; Fink JN; Frayne JH; Gerraty RP; Hankey GJ; Hodgkinson SJ; Hughes JT; Ingall TJ; Landau PB; Lindley RI; Long PW; Markus R; Mullins EM; Parsons MW; Pollack MRP; Read SJ; Rosen DM; Schultz DW; Serisier DE; Watson JDG; Storey CE; Zagami AA, 2004, 'Tissue plasminogen activator (tPA) in acute ischaemic stroke: Time for collegiate communication and consensus', Medical Journal of Australia, vol. 180, pp. 634 - 636
2004
Tran GT; Hodgkinson SJ; Carter N; Killingsworth M; Spicer ST; Hall BM, 2002, 'Attenuation of experimental allergic encephalomyelitis in complement component 6-deficient rats is associated with reduced complement C9 deposition, P-selectin expression, and cellular infiltrate in spinal cords', Journal of Immunology, vol. 168, pp. 4293 - 4300, http://dx.doi.org/10.4049/jimmunol.168.9.4293
2002
Hodgkinson SJ, 2001, 'Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?', Journal of Clinical Neuroscience, vol. 8, pp. 378 - 379, http://dx.doi.org/10.1054/jocn.2001.0911
2001
Tran GT; Carter N; He XY; Spicer ST; Plain KM; Nicolls M; Hall BM; Hodgkinson SJ, 2001, 'Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAB therapy with a preferential effect on Th1 cells that is augmented by IL-4', International Immunology, vol. 13, pp. 1109 - 1120, http://dx.doi.org/10.1093/intimm/13.9.1109
2001
Tran GT; Carter N; Hodgkinson SJ, 2001, 'Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis', International Immunopharmacology, vol. 1, pp. 1709 - 1723, http://dx.doi.org/10.1016/S1567-5769(01)00081-9
2001
Spicer ST; Ha H; Boyd RA; He XY; Carter N; Tran GT; Penny MJ; Hodgkinson SJ; Hall BM, 2001, 'IL-4 Therapy Prevents the development of proteinuria in active Heymann Nephritis by inhibition of Tc1 cells', Journal of Immunology, vol. 167, pp. 3725 - 3733, http://dx.doi.org/10.4049/jimmunol.167.7.3725
2001
Hall BM; Hodgkinson SJ; Quin JW, 1999, 'Corticosteroids in Autoimmunity', Australian Prescriber, pp. 15 - 18
1999
Hall BM; Hodgkinson SJ; Quin JW, 1998, 'Corticosteroids in autoimmune diseases.', Australian Prescriber, vol. 22, pp. 9 - 11
1998
Hu P; Pollard J; Hunt N; Taylor J; Hodgkinson S; Tran G; ChanLing T, 1997, 'Pathogenesis of optic neuritis in experimental allergic encephalomyelitis (EAE)', BRAIN PATHOLOGY, vol. 7, pp. 1363 - 1363, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XQ52700525&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1997
Van Oosten BW; Lai M; Hodgkinson S; Barkhof F; Miller DH; Moseley IF; Thompson AJ; Rudge P; McDougall A; McLeod JG; Adèr HJ; Polman CH, 1997, 'Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled, MR- monitored phase II trial', Neurology, vol. 49, pp. 351 - 357, http://dx.doi.org/10.1212/WNL.49.2.351
1997
Van Oosten BW; Lai M; Barkhof F; Miller DH; Moseley IF; Thompson AJ; Hodgkinson S; Polman CH, 1996, 'A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosis', Multiple Sclerosis, vol. 1, pp. 339 - 342, http://dx.doi.org/10.1177/135245859600100611
1996
Murwani R; Hodgkinson S; Armati P, 1996, 'Tumor necrosis factor α and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon γ stimulation', Journal of Neuroimmunology, vol. 71, pp. 65 - 71, http://dx.doi.org/10.1016/S0165-5728(96)00131-2
1996
Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J, 1996, 'Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis', Annals of Neurology, vol. 39, pp. 6 - 16, http://dx.doi.org/10.1002/ana.410390104
1996
Hodgkinson SJ; Westland KW; Pollard JD, 1994, 'Transfer of experimental allergic neuritis by intra neural injection of sensitized lymphocytes', Journal of the Neurological Sciences, vol. 123, pp. 162 - 172, http://dx.doi.org/10.1016/0022-510X(94)90219-4
1994
Lindsey RJW; Hodgkinson S; Mehta R; Mitchell D; Enzmann D; Steinman L, 1994, 'Repeated treatment with chimeric anti‐CD4 antibody in multiple sclerosis', Annals of Neurology, vol. 36, pp. 183 - 189, http://dx.doi.org/10.1002/ana.410360210
1994
Lindsey JW; Hodgkinson S; Mehta R; Siegel RC; Mitchell DJ; Lim M; Piercy C; Tram T; Dorfman L; Enzmann D; Steinman L, 1994, 'Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis', Neurology, vol. 44, pp. 413 - 419
1994
Bell RB; Lindsey JW; Sobel RA; Hodgkinson S; Steinman L, 1993, 'Diverse T cell receptor Vβ gene usage in the central nervous system in experimental allergic encephalomyelitis', Journal of Immunology, vol. 150, pp. 4085 - 4092
1993
Steinman L; Lindsey JW; Alters S; Hodgkinson S, 1993, 'From treatment of experimental allergic encephalomyelitis to clinical trials in multiple sclerosis.', Immunology series, vol. 59, pp. 253 - 260
1993
Knox SJ; Levy R; Hodgkinson S; Bell R; Brown S; Wood GS; Hoppe R; Abel EA; Steinman L; Berger RG; Gaiser C; Young G; Bindl J; Hanham A; Reichert T, 1991, 'Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoides', Blood, vol. 77, pp. 20 - 30
1991
Smilek DE; Wraith DC; Hodgkinson S; Dwivedy S; Steinman L; McDevitt HO, 1991, 'A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis', Proceedings of the National Academy of Sciences of the United States of America, vol. 88, pp. 9633 - 9637, http://dx.doi.org/10.1073/pnas.88.21.9633
1991
Hodgkinson SJ; Pollard JD; McLeod JG, 1990, 'Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy', Journal of Neurology Neurosurgery and Psychiatry, vol. 53, pp. 327 - 330, http://dx.doi.org/10.1136/jnnp.53.4.327
1990
Sakai K; Zamvil SS; Mitchell DJ; Hodgkinson S; Rothbard JB; Steinman L, 1989, 'Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins', Proceedings of the National Academy of Sciences of the United States of America, vol. 86, pp. 9470 - 9474, http://dx.doi.org/10.1073/pnas.86.23.9470
1989
Conference Abstracts
add
Trewin BP; Tilling J; Levy S; Hodgkinson SJ, 2019, 'Response to Immunosuppressive Therapy in Cerebral Amyloid Angiopathy-related Inflammation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Sydney, AUSTRALIA, Vol. 25, pp. 492 - 492, presented at Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Sydney, AUSTRALIA, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000460691800161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Verma N; Lam A; Chiu C; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM, 2018, 'Alloactivation of Human CD4+CD25+CD127loCD45RA-Fox3hi Treg Population to Induce Potential Alloantigen Specific Treg', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Madrid, SPAIN, Vol. 102, pp. S145 - S145, presented at 27th International Congress of the Transplantation-Society (TTS), Madrid, SPAIN, 30 June 2018 - 05 July 2018, http://dx.doi.org/10.1097/01.tp.0000542769.25232.5b
2018
Chiu CHY; Lam AD; Verma ND; Tran GT; Robinson CM; Hall BM; Hodgkinson SJ, 2018, 'Activation of Human Naive T Regulatory Cells for MS Therapy By Stimulation with Antigen and Interleukin-4', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, San Diego, CA, Vol. 24, pp. 89 - 89, presented at ACTRIMS Forum, San Diego, CA, 01 February 2018 - 03 February 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429034600198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2018
Lam AD; Chiu CHY; Verma ND; Robinson CM; Tran GT; Hall BM; Hodgkinson SJ, 2018, 'Phenotypic Analysis of T Regulatory Cells in Multiple Sclerosis Patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, San Diego, CA, Vol. 24, pp. 93 - 94, presented at ACTRIMS Forum, San Diego, CA, 01 February 2018 - 03 February 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429034600207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2018
Bhaskar S; Thomas P; Cappelen-Smith C; McDougall A; Hodgkinson S; Cordato D, 2018, 'Factors associated with delayed hospital presentation for acute stroke events in South Western Sydney', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, Vol. 13, pp. 24 - 24, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440952200111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2018
Merkel B; Jokubaitis V; Spelman T; Lechner-Scott J; McCombe P; Slee M; Vucic S; Skibina O; Barnett M; Hodgkinson S; Butzkueven H; Kalincik T, 2017, 'TIMING OF HIGH-EFFICACY DISEASE MODIFYING THERAPIES FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, Gold Coast, AUSTRALIA, Vol. 88, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), Gold Coast, AUSTRALIA, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.16
2017
Stewart T; Spelman T; Havrdova E; Horakova D; Trojano M; Izquierdo G; Duquette P; Girard M; Prat A; Lugaresi A; Grand'Maison F; Grammond P; Sola P; Shaygannejad V; Hupperts R; Alroughani R; Oreja-Guevara C; Pucci E; Boz C; Lechner-Scott J; Bergamaschi R; Van Pesch V; Iuliano G; Ramo C; Taylor B; Slee M; Spitaleri D; Granella F; Verheul F; McCombe P; Hodgkinson S; Amato MP; Vucic S; Gray O; Cristiano E; Barnett M; Sanchez Menoyo JL; Van Munster E; Saladino ML; Olascoaga J; Prevost J; Deri N; Shaw C; Singhal B; Moore F; Rozsa C; Shuey N; Skibina O; Kister I; Petkovska-Boskova T; Ampapa R; Kermode A; Butzkueven H; Jokubaitis V; Kalincik T, 2017, 'Contribution of different relapse phenotypes to disability in multiple sclerosis', in Multiple Sclerosis, Vol. 23, pp. 266 - 276, http://dx.doi.org/10.1177/1352458516643392
2017
Kalincik T; Lizak N; Jokubaitis V; Butler E; Lechner-Scott J; Slee M; McCombe P; Shaw C; Skibina O; Vucic S; Shuey N; Barnett M; Parratt J; Butzkueven H; Hodgkinson S, 2016, 'Australian cladribine experience', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, London, ENGLAND, Vol. 22, pp. 289 - 290, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, ENGLAND, 14 September 2016 - 17 September 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201360&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Haartsen J; Spelman T; Baker J; Agland S; Lechner-Scott J; Burke T; Vucic S; Rath L; Skibina O; Toubia M; Slee M; McGregor S; Taylor B; O'Connell A; Barnett M; Baker S; Sharma M; Hodgkinson S; Walters S; Kermode A; Hayes W; Butler E; Shuey N; Shaw C; Portley R; Hardy T; Tan IL; Butzkueven H, 2016, 'MSFIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, London, ENGLAND, Vol. 22, pp. 342 - 343, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, ENGLAND, 14 September 2016 - 17 September 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201443&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Hall B; Robinson C; Plain K; Verma N; Tran G; Carter N; Nomura M; Boyd R; Hodgkinson S, 2016, 'In Vitro Reactivity of CD4(+) T Cells Subsets from Hosts with Antigen Specific Transplant Tolerance Mediated by CD4(+)CD25(+) T Cells', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, Boston, MA, Vol. 16, pp. 512 - 512, presented at American Transplant Congress, Boston, MA, 11 June 2016 - 15 June 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383373903337&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2016
Jokubaitis VG; Kalincik T; Lorscheider J; Spelman T; Horakova D; Duquette P; Girard M; Prat A; Izquierdo G; Grammond P; Pucci E; Grand'Maison F; Granella F; Sola P; Bergamaschi R; Iuliano G; Spitaleri D; Hodgkinson S; Olascoaga J; Verheul F; McCombe P; Rozsa C; Lechner-Scott J; Terzi M; Hughes S; Saladino M-L; Lugaresi A; Trojano M; Butzkueven H, 2016, 'Pregnancy protects against long-term disability accrual in relapsing-remitting MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, London, ENGLAND, Vol. 22, pp. 120 - 122, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, ENGLAND, 14 September 2016 - 17 September 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Kalincik T; Sobisek L; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Izquierdo G; Lugaresi A; Girard M; Prat A; Duquette P; Grammond P; Sola P; Hupperts R; Grand'Maison F; Pucci E; Boz C; Alroughani R; Van Pesch V; Lechner-Scott J; Terzi M; Bergamaschi R; Iuliano G; Granella F; Spitaleri D; Shaygannejad V; Oreja-Guevara C; Slee M; Ampapa R; Verheul F; McCombe P; Olascoaga J; Amato MP; Vucic S; Hodgkinson S; Ramo C; Flechter S; Cristiano E; Rozsa C; Moore F; Sanchez-Menoyo JL; Saladino ML; Barnett M; Butzkueven H, 2016, 'Individual response to disease modifying therapies: a global observational cohort study', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, London, ENGLAND, Vol. 22, pp. 358 - 360, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, ENGLAND, 14 September 2016 - 17 September 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201468&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Kalincik T; Brown JW; Robertson N; Willis M; Scolding N; Pearson O; Ziemssen T; Hutchinson M; McGuigan C; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Izquierdo G; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Alroughani R; Pucci E; Sola P; Hupperts R; Lechner-Scott J; Fernandez Bolanos R; Terzi M; Van Pesch V; Rozsa C; Grand'Maison F; Boz C; Granella F; Slee M; Spitaleri D; Olascoaga J; Bergamaschi R; Iuliano G; Verheul F; Vucic S; McCombe P; Hodgkinson S; Kovacs K; Sanchez-Menoyo JL; Ampapa R; Simo M; Ramo C; Cristiano E; Barnett M; Butzkueven H; Coles A, 2016, 'Comparison of 5-year treatment outcomes between alemtuzumab versus natalizumab, fingolimod and interferon beta-1a', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, London, ENGLAND, Vol. 22, pp. 829 - 832, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, ENGLAND, 14 September 2016 - 17 September 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267203257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Jokubaitis V; Spelman T; Kalincik T; Lorscheider J; McCombe P; Lechner-Scott J; Hodgkinson S; Butzkueven H, 2015, 'First-line injectable therapy and pregnancy protect against long-term disability accrual in patients with relapse-onset multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Melbourne, AUSTRALIA, Vol. 21, pp. NP15 - NP15, presented at MS Research Australia Progress in MS Research Conference, Melbourne, AUSTRALIA, 29 October 2015 - 30 October 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365611900037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Haartsen J; Agland S; Baker J; Burke T; Rath L; Lechner-Scott J; Taylor B; Vucic S; Barnett M; Slee M; Hodgkinson S; Skibina O; Kermode A; Butler E; Shuey N; Shaw C; Hardy T; Tan IL; Butzkueven H; Spelman T, 2015, 'MS FIRST - utilising a drug safety module for use in MS clinical practice to evaluate lymphocyte reduction in fingolimod treatment over time, demographic predictors of lymphopenia and association with reported safety events', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Barcelona, SPAIN, Vol. 21, pp. 18 - 19, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, 07 October 2015 - 10 October 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729400025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Butzkueven H; Barnett M; Broadley S; Hodgkinson S; King J; Kneebone C; Slee M; Lechner-Scott J; Kermode A; Shuey N; Macdonell R; Chen Y; Naidoo K; Koendgen H, 2015, 'Efficacy and Safety of Natalizumab in Multiple Sclerosis: Interim Observational Program Results from an Australian Cohort.', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Seoul, SOUTH KOREA, Vol. 22, pp. 419 - 420, presented at 8th Congress of the Pan-Asian-Committee-for-Research-and-Treatment-of-Multiple-Sclerosis (PACTRIMS), Seoul, SOUTH KOREA, 19 November 2015 - 21 November 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000372242400088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Hodgkinson S; Tran G; Dent L; Robinson C; Wilcox P; Hall BM, 2015, 'Interleukin 5 mediates disease protection associated with parasite infestation in EAE', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Barcelona, SPAIN, Vol. 21, pp. 430 - 430, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, 07 October 2015 - 10 October 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729401234&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Hodgkinson S; Tran G; Robinson C; Wilcox P; Hall R; Hall BM, 2015, 'Natural CD4(+)CD25(+)T regulatory cells (nTreg) cultured with antigen and Th2 cytokines, suppress induction of EAE', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Barcelona, SPAIN, Vol. 21, pp. 537 - 537, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, 07 October 2015 - 10 October 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729401427&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Gonsalvez D; Wood R; Wong A; Tran G; Hodgkinson S; Hughes R; Giuffrida L; Kilpatrick T; Murray S; Xiao J, 2015, 'A novel small molecule neurotrophin-based strategy for treating demyelinating diseases', in JOURNAL OF NEUROCHEMISTRY, WILEY-BLACKWELL, Cairns, AUSTRALIA, Vol. 134, pp. 285 - 285, presented at 25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society, Cairns, AUSTRALIA, 23 August 2015 - 27 August 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360206300717&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2015
Hall BM; Robinson CM; Tran GT; Verma ND; Boyd RA; Hodgkinson SJ, 2015, 'RECENTLY ALLOACTIVATED CD4+CD8-CD25+TREG EXPRESS CD8 AND ARE THE ANTIGEN SPECIFIC TREG', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, ANU Campus, Canberra, AUSTRALIA, Vol. 93, pp. A29 - A29, presented at 33rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New Zealand, ANU Campus, Canberra, AUSTRALIA, 21 June 2015 - 23 June 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363320100073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Robinson CM; Tran GT; Hall RM; Wilcox P; Hodgkinson SJ; Hall BM, 2015, 'INDUCTION OF POTENT ANTIGEN SPECIFIC TREG CELLS FROM NAIVE TTREG BY ALLOANTIGEN AND TH2 CYTOKINES', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, ANU Campus, Canberra, AUSTRALIA, Vol. 93, pp. A31 - A31, presented at 33rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New Zealand, ANU Campus, Canberra, AUSTRALIA, 21 June 2015 - 23 June 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363320100078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Hall BM; Robinson CM; Tran GT; Verma ND; Boyd RA; Hodgkinson SJ, 2015, 'Recently alloactivated CD4+CD8-CD25+TREG express CD8 and are the antigen-specific TREG', in Transplantation, Lippincott, Williams & Wilkins, Lorne, AUSTRALIA, Vol. 99, pp. S34 - S34, presented at 14th Transplantation Science Symposium of the Transplantation-Society (TSS), Lorne, AUSTRALIA, 11 November 2015 - 13 November 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000368625900061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2015
Lizak N; Lugaresi A; Alroughani R; Lechner-Scott J; Slee M; Hodgkinson S; Jokubaitis V; Spelman T; Butzkueven H; Kalincik T, 2015, 'Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Melbourne, AUSTRALIA, Vol. 21, pp. NP14 - NP14, presented at MS Research Australia Progress in MS Research Conference, Melbourne, AUSTRALIA, 29 October 2015 - 30 October 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365611900036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Jokubaitis VG; Spelman T; Kalincik T; Travaglini D; Paolicelli D; Duquette P; Girard M; Prat A; Havrdova E; Horakova D; Izquierdo G; Grammond P; Pucci E; Grand'Maison F; Bergamaschi R; Granella F; Van Pesch V; Hupperts R; Iuliano G; Spitaleri D; Sola P; Boz C; Fernandez-Bolanos R; Petersen T; Verheul F; Olascoaga J; McCombe P; Rozsa C; Lechner-Scott J; Terzi M; Hodgkinson S; Ramo C; Saladino ML; Butzkueven H; Lugaresi A; Trojano M, 2015, '10-year progression predictors after first treatment initiation in a relapsing-remitting MS cohort', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Barcelona, SPAIN, Vol. 21, pp. 100 - 102, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, 07 October 2015 - 10 October 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729400172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Hodgkinson SJ; Hall BM; Hall RM; Tran GT; Robinson CM; Wang C; Sharland A, 2015, 'INTERLEUKIN-5 THERAPY PREVENTS CHRONIC ALLOGRAFT REJECTION BY INDUCTION OF T REGULATORY CELLS', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, ANU Campus, Canberra, AUSTRALIA, Vol. 93, pp. A31 - A31, presented at 33rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New Zealand, ANU Campus, Canberra, AUSTRALIA, 21 June 2015 - 23 June 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363320100077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Hodgkinson SJ; Hall BM; Hall RM; Tran GT; Robinson CM; Wang C; Sharland A, 2015, 'Interleukin-5 therapy prevents chronic allograft rejection by introduction of T regulatory cells.', in Transplantation, Lippincott, Williams & Wilkins, Lorne, AUSTRALIA, Vol. 99, pp. S4 - S4, presented at 14th Transplantation Science Symposium of the Transplantation-Society (TSS), Lorne, AUSTRALIA, 11 November 2015 - 13 November 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000368625900008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2015
Lizak N; Lugaresi A; Alroughani R; Lechner-Scott J; Slee M; Havrdova E; Horakova D; Trojano M; Izquierdo G; Duquette P; Girard M; Prat A; Grammond P; Hupperts R; Sola P; Grand'Maison F; Bergamaschi R; Pucci E; Oreja-Guevara C; Cabrera-Gomez JA; Van Pesch V; Petersen T; Boz C; Ramo C; Rio ME; Iuliano G; Fernandez-Bolanos R; Granella F; Spitaleri DLA; Verheul F; Terzi M; Rozsa C; Amato MP; Olascoaga J; Flechter S; Cristiano E; Rojas JI; Hodgkinson S; Jokubaitis V; Spelman T; Butzkueven H; Kalincik T, 2015, 'Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Barcelona, SPAIN, Vol. 21, pp. 308 - 310, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, 07 October 2015 - 10 October 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729401014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Spelman T; Mekhael L; Burke T; Butzkueven H; Hodgkinson S; Havrdova E; Horakova D; Duquette P; Izquierdo G; Grand'Maison F; Grammond P; Barnett M; Lechner-Scott J; Alroughani R; Trojano M; Lugaresi A; Granella F; Pucci E; Vucic S, 2015, 'Risk of early relapse following switch to oral agents for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Barcelona, SPAIN, Vol. 21, pp. 270 - 271, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, 07 October 2015 - 10 October 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729400466&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Stewart T; Jokubaitis V; Spelman T; Havrdova E; Horakova D; Trojano M; Izquierdo G; Girard M; Duquette P; Prat A; Lugaresi A; Grammond P; Grand'Maison F; Sola P; Hupperts R; Petersen T; Pucci E; Bergamaschi R; Boz C; Oreja-Guevara C; Lechner-Scott J; Alroughani R; Ramo C; Van Pesch V; Fernandez-Bolanos R; Iuliano G; Rio ME; Granella F; Slee M; Verheul F; Spitaleri DLA; Amato MP; Hodgkinson S; McCombe P; Cabrera-Gomez JA; Barnett M; Flechter S; Olascoaga J; Vucic S; Sanchez-Menoyo JL; Cristiano E; Saladino ML; Moore F; Gray O; Shuey N; Rozsa C; Singhal B; Shaw C; Butzkueven H; Kalincik T, 2015, 'Effect of relapse phenotype on the accumulation of disability in relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Barcelona, SPAIN, Vol. 21, pp. 726 - 728, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, 07 October 2015 - 10 October 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729402256&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Robinson C; Hall B; Plain K; Tran G; Verma N; Boyd R; Nomura M; Hodgkinson S, 2014, 'The Test for Tolerance - Diagnosing Transplant Tolerance By In Vitro Assay of CD4(+)CD25(+)T Cells', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, San Francisco, CA, Vol. 14, pp. 401 - 401, presented at World Transplant Congress, San Francisco, CA, 26 July 2014 - 31 July 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000338033301672&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
He A; Spelman T; Jokubaitis V; Lugaresi A; Izquierdo G; Trojano M; Grammond P; Lechner-Scott J; Duquette P; Girard M; Pucci E; Slee M; Grand'Maison F; Oreja-Guevara C; Boz C; Fernandez-Bolanos R; Hodgkinson S; Sanchez-Menoyo J; Iuliano G; Barnett M; Moore F; Butzkueven H; Kalincik T, 2014, 'Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Boston, MA, Vol. 20, pp. 193 - 193, presented at Joint ACTRIMS-ECTRIMS Meeting, Boston, MA, 10 September 2014 - 13 September 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354441300448&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Kalincik T; Horakova D; Spelman T; Jokubaitis V; Trojano M; Lugaresi A; Izquierdo G; Rozsa C; Grammond P; Alroughani R; Duquette P; Girard M; Pucci E; Lechner-Scott J; Slee M; Fernandez-Bolanos R; Grand'Maison F; Hupperts R; Verheul F; Hodgkinson S; Oreja-Guevara C; Spitaleri D; Barnett M; Terzi M; Bergamaschi R; McCombe P; Sanchez-Menoyo J; Simo M; Csepany T; Rum G; Boz C; Havrdova E; Butzkueven H, 2014, 'Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Boston, MA, Vol. 20, pp. 195 - 196, presented at Joint ACTRIMS-ECTRIMS Meeting, Boston, MA, 10 September 2014 - 13 September 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354441300452&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Kalincik T; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Izquierdo G; Girard M; Duquette P; Lugaresi A; Grand'Maison F; Grammond P; Hupperts R; Oreja-Guevara C; Pucci E; Boz C; Bergamaschi R; Lechner-Scott J; Alroughani R; Van Pesch V; Iuliano G; Rio M; Fernandez-Bolanos R; Ramo C; Terzi M; Petersen T; Slee M; Spitaleri D; Amato MP; Verheul F; Cristiano E; Sanchez-Menoyo J; Fiol M; Gray O; Cabrera-Gomez J; Hodgkinson S; Barnett M; Saladino M; Vucic S; Shaw C; Moore F; Van Munster E; Rozsa C; McCombe P; Butzkueven H, 2014, 'Evaluation of common criteria of progression of disability in a large observational cohort', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Boston, MA, Vol. 20, pp. 62 - 63, presented at Joint ACTRIMS-ECTRIMS Meeting, Boston, MA, 10 September 2014 - 13 September 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354441300154&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Hodgkinson SJ; Hall RM; Tran GT; Robinson CM; Wang C; Sharland A; Hall BM, 2014, 'Interleukin-5 Therapy Prevents Chronic Allograft Rejection By Induction of T Regulatory Cells', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, ANU Campus, Canberra, AUSTRALIA, Vol. 92, pp. A25 - A25, presented at 32nd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, ANU Campus, Canberra, AUSTRALIA, 10 June 2014 - 13 June 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342376300061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Hall BM; Verma ND; Plain KM; Robinson CM; Boyd R; Tran GT; Wang C; Bishop GA; Hodgkinson SJ, 2014, 'INTERLEUKIN-12 PROMOTES INDUCTION OF POTENT TH1-LIKE CD4(+)CD25(+)T REGULATORY CELLS THAT INHIBIT ALLOGRAFT REJECTION IN UNMODIFIED HOSTS', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, ANU Campus, Canberra, AUSTRALIA, Vol. 92, pp. A24 - A24, presented at 32nd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, ANU Campus, Canberra, AUSTRALIA, 10 June 2014 - 13 June 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342376300058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Hodgkinson S; Hall R; Tran G; Robinson C; Wang C; Sharland A; Hall B, 2014, 'Interleukin-5 Therapy Prevents Chronic Allograft Rejection By Induction of T Regulatory Cells', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, San Francisco, CA, Vol. 14, pp. 403 - 403, presented at World Transplant Congress, San Francisco, CA, 26 July 2014 - 31 July 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000338033301678&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Robinson C; Hall B; Plain K; Tran G; Verma N; Boyd R; Nomura M; Hodgkinson S, 2014, 'The Test for Tolerance - Diagnosing Transplant Tolerance By In Vitro Assay of CD4(+)CD25(+)T Cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, San Francisco, CA, Vol. 98, pp. 401 - 401, presented at World Transplant Congress, San Francisco, CA, 26 July 2014 - 31 July 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339104602279&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Hodgkinson S; Hall R; Tran G; Robinson C; Wang C; Sharland A; Hall B, 2014, 'Interleukin-5 Therapy Prevents Chronic Allograft Rejection By Induction of T Regulatory Cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, San Francisco, CA, Vol. 98, pp. 403 - 403, presented at World Transplant Congress, San Francisco, CA, 26 July 2014 - 31 July 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339104602285&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Robinson CM; Hall BM; Plain KM; Tran GT; Verma ND; Boyd R; Nomura M; Hodgkinson SJ, 2014, 'THE TEST FOR TOLERANCE: TEST OF TRANSPLANT TOLERANCE BY IN VITRO ASSAY OF CD4(+)CD25(+)T CELLS', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, ANU Campus, Canberra, AUSTRALIA, Vol. 92, pp. A23 - A23, presented at 32nd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, ANU Campus, Canberra, AUSTRALIA, 10 June 2014 - 13 June 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342376300056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Hall B; Verma N; Plain K; Robinson C; Boyd R; Tran G; Wang C; Bishop G; Hodgkinson S, 2014, 'Interleukin-12 Promotes Induction of Potent Th1-Like CD4(+)CD25(+)T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Hosts.', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, San Francisco, CA, Vol. 98, pp. 24 - 24, presented at World Transplant Congress, San Francisco, CA, 26 July 2014 - 31 July 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339104600071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Murray S; Hughes R; Tran G; Hodgkinson S; Wong A; Peckham H; Ferner A; Giuffrida L; Kilpatrick TJ; Xiao J, 2013, 'A BDNF MIMETIC PROMOTES PERIPHERAL MYELIN DEVELOPMENT AND AMELIORATES EXPERIMENTAL AUTOIMMUNE NEURITIS (EAN)', in GLIA, WILEY-BLACKWELL, Berlin, GERMANY, Vol. 61, pp. S85 - S85, presented at 11th European Meeting on Glial Cell Function in Health and Disease, Berlin, GERMANY, 03 July 2013 - 06 July 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000320408400263&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Lee E; Lu B; Roussel J; Murray-Segal L; Salvaris E; Hodgkinson S; Hall B; d'Apice A; Cowan P; Gock H, 2012, 'SIGNIFICANT PROTECTION BY EPCR OVEREXPRESSION IN MOUSE MODELS OF TRANSPLANTATION', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 17, pp. 75 - 75, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307544400186&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Lee E; Lu B; Murray-Segal L; Salvaris E; Hall B; Hodgkinson S; D'Apice A; Cowan P; Gock H, 2011, 'OVEREXPRESSING ENDOTHELIAL PROTEIN C RECEPTOR PROTECTS AGAINST INFLAMMATION AND THROMBOSIS IN MODELS OF ORGAN TRANSPLANTATION', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 16, pp. 24 - 24, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294977600002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Lee E; Murray-Segal L; Salvaris E; Roussel JC; Hall B; Hodgkinson S; d'Apice A; Gock H; Cowan P, 2011, 'Protective effects of EPCR overexpression in mouse cardiac xenografts and islet isografts', in XENOTRANSPLANTATION, WILEY-BLACKWELL, Miami, FL, Vol. 18, pp. 295 - 295, presented at Joint International Congress of the Cell-Transplant-Society(CTS)/International-Xenotransplantation-Association (IXA), Miami, FL, 23 October 2011 - 26 October 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295092900092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Hodgkinson SJ; Tran GT; Carter N; Verma ND; Plain KM; Robinson C; Killingsworth MC; Boyd RA; Hall BM, 2009, 'INTERLEUKIN 5 (IL-5) PREVENTS AUTOIMMUNE MEDIATED DEMYELINATION BY ACTIVATION OF ANTIGEN SPECIFIC CD4+CD25+T REGULATORY CELLS', in Journal of the Peripheral Nervous System, Woodland Publications, New York, NY, USA, Vol. 14, pp. 65 - 65, presented at Annual Meeting of the Peripheral-Nerve-Society, Wurzburg, GERMANY
2009
Tran GT; Hodgkinson SJ; Carter N; Killingsworth MC; Nomura M; Verma ND; Plain KM; Boyd RA; Hall BM, 2009, 'MEMBRANE ATTACK COMPLEX OF COMPLEMENT IS NOT ESSENTIAL FOR IMMUNE MEDIATED DEMYELINATION BUT IS ASSOCIATED WITH REDUCED TH17', in Journal of the Peripheral Nervous System, Woodland Publications, New York, NY, USA, Vol. 14, pp. 145 - 145, presented at Annual Meeting of the Peripheral-Nerve-Society, Wurzburg, GERMANY, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269527000332&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2009
Verma N; Plain K; Nomura M; Robinson C; Boyd R; Tran G; Carter N; Hodgkinson SJ; Hall B, 2007, 'TH1 AND TH2 RESPONSES INDUCE SEPARATE LINEAGES OF CD4+CD25+T CELLS THAT MEDIATE ALLOGRAFT TOLERANCE', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 12, pp. A14 - A14, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2007
Verma N; Plain K; Tran G; Boyd R; Hodgkinson SJ; Carter N; Robinson C; Hall B, 2007, 'ALLOGRAFT TOLERANCE MEDIATING CD4+T CELLS DEPEND UPON INTERFERON-GAMMA (IFN-gamma) OR INTERLEUKIN-5 (IL-5)', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 12, pp. A17 - A17, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2007
Boyd R; Hodgkinson SJ; Carter N; Tran G; Plain K; Verma N; Robinson C; Hall B, 2007, 'ABSENCE OF MEMBRANE ATTACK COMPLEX (MAC), DELAYS ONSET OF PROTEINURIA IN HEYMANN NEPHRITIS (HN)', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 12, pp. A12 - A12, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2007
Plain KM; Verma ND; Tran GT; Boyd RA; Nomura M; Robinson C; Hodgkinson SJ; Hall BM, 2006, 'IL-4 does not maintain specific tolerance mediating CD4+CD25+ t suppressor cells but induces antigen-specific naïve CD4+CD25+ T cells.', in Transplantation, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 420 - 420, presented at World Transplant Congress 2006, Boston, Massachusetts, 24 July 2006 - 27 July 2006
2006
Buchanan A; Wang C; Tran GT; Hodgkinson SJ; Hall BM; Mccaughan GW; Allen R; Bishop G, 2006, 'Role of IL-4 in rat liver allograft rejection', in Immunology and Cell Biology, Blackwell Publishing Asia, Australian Acad Sci, Canberra, AUSTRALIA, Vol. 84, pp. A28 - A28, presented at 24th Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, Australian Acad Sci, Canberra, AUSTRALIA, 29 March 2006 - 31 March 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237063000098&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2006
Hodgkinson SJ; Robinson C; Plain KM; Hall BM; Carter N; Tran GT; Verma ND, 2006, 'Antigen-specific CD4+CD25+ T cells prevent induction of demyelination in experimental allergic neuritis', in Multiple Sclerosis, Arnold, Madrid, SPAIN, Vol. 12, pp. S50 - S50, presented at 22nd Congress of the European-Committee-for-the-Treatment-and-Resarch-in-Multiple-Sclerosis, Madrid, SPAIN, 27 September 2006 - 30 September 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241921400162&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2006
Plain KM; Verma ND; Tran GT; Boyd RA; Nomura M; Robinson C; Hodgkinson SJ; Hall BM, 2006, 'IL-4 Does Not Promote Survival Of Specific Tolerance Mediating CD4+ And CD4+CD25+ T Cells.', in TSANZ - 24th Australian Academy of Science, TSANZ - 24th Australian Academy of Science, Canberra, pp. 112 - 112, presented at TSANZ - 24th Australian Academy of Science, Canberra, 29 March 2006 - 31 March 2006
2006
Lam V; Laurence JA; Sharland A; McCaughan G; Hodgkinson SJ; Hall BM; Allen R; Bishop A, 2006, 'Induction of long-term cardiac allograft survival using anti-lymphocyte antibodies in the rat model', in TSANZ - 24th Australian Academy of Science, TSANZ - 24th Australian Academy of Science, Canberra, pp. 113 - 113, presented at TSANZ - 24th Australian Academy of Science, Canberra, 29 March 2006 - 31 March 2006
2006
Tran GT; Carter N; Killingsworth MC; Nomura M; Hall BM; Hodgkinson SJ, 2006, 'The role of MAC in complement component C6 deficient Lewis rat.', in Journal of Neuroimmunology, Elsevier Science BV, Amsterdam, Netherlands, pp. 58 - 58, presented at 8th International Conference of Neuroimmunology, Japan, 01 October 2006
2006
Verma ND; Nomura M; Plain KM; Robinson C; Tran GT; Boyd RA; Hodgkinson SJ; Hall BM, 2006, 'Short-Term Culture Of Naive CD4+CD25+ T Cell ith Alloantigen And Either IL-2 Or IL-4 Induced s W Cells That Inhibit Speciic Allograft Rejection', in TSANZ - 24th Australian Academy of Science, TSANZ - 24th Australian Academy of Science, Canberra, pp. 44 - 44, presented at TSANZ - 24th Australian Academy of Science, Canberra, 29 March 2006 - 31 March 2006
2006
Buchanan A; Wang C; Tran GT; Hodgkinson SJ; Hall BM; McCaughan G; Allen R; Bishop A, 2006, 'Role of IL-4 in rat liver allograft rejection', in TSANZ - 24th Australian Academy of Science, TSANZ - 24th Australian Academy of Science, Canberra, pp. 114 - 114, presented at TSANZ - 24th Australian Academy of Science, Canberra, 29 March 2006 - 31 March 2006
2006
Hodgkinson SJ; Tran GT; Carter M; Vernia M; Plain KM; Killingsworth MC; Hall BM, 2006, 'Therapy with interleukin 5 suppresses autoimmune T cell-mediated peripheral nerve demyelination in EAN and increases CD34+CD25+ cells', in Multiple Sclerosis, Arnold, Madrid, SPAIN, Vol. 12, pp. S51 - S51, presented at 22nd Congress of the European-Committee-for-the-Treatment-and-Resarch-in-Multiple-Sclerosis, Madrid, SPAIN, 27 September 2006 - 30 September 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241921400164&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2006
Hodgkinson SJ; Nomura M; Tran GT; Verma ND; Plain KM; Boyd RA; Hall BM, 2006, 'TRANSPLANT TOLERANCE MEDIATING CD4+ T CELLS CONTAIN CD4+CD25+ CELLS THAT EXPRESS INTERFERON-GAMMA RECEPTOR (IFNGR) AND THEIR SURIVAL IS PROMOTED BY IFN-y', in Transplantation, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 612 - 612, presented at World Transplant Congress 2006, Boston, Massachusetts, 24 July 2006 - 27 July 2006
2006
Boyd RA; Nomura M; Hodgkinson SJ; Carter N; Tran GT; Plain KM; Verma ND; Hall BM, 2006, 'Lack Of Complement Component 6 And Lack Of Formation Of The Membrane Attack Complex Has No Effect On Allograft Rejection In Lewis Rats', in TSANZ - 24th Australian Academy of Science, TSANZ - 24th Australian Academy of Science, Canberra, pp. 112 - 112, presented at TSANZ - 24th Australian Academy of Science, Canberra, 29 March 2006 - 31 March 2006
2006
Hall BM; Plain KM; Robinson C; Nomura M; Verma ND; Boyd RA; Tran GT; Hodgkinson SJ, 2006, 'A test to detect specific immune tolerance to transplanted organs by examining in vitro reactivity of peripheral CD4+ T cells and the CD25+ and CD25- subsets.', in Transplantation, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 613 - 613, presented at World Transplant Congress 2006, Boston, Massachusetts, 24 July 2006 - 27 July 2006
2006
Hall BM; Plain KM; Robinson C; Nomura M; Verma ND; Boyd RA; Tran GT; Hodgkinson SJ, 2006, 'In Vitro Reactivity Of CD4+ , CD4+ CD25+, And The CD4+CD25+T Cell Subsets From Rats With Tolerance To A Cardiac Allograft', in TSANZ - 24th Australian Academy of Science, TSANZ - 24th Australian Academy of Science, Canberra, pp. 111 - 111, presented at TSANZ - 24th Australian Academy of Science, Canberra, 29 March 2006 - 31 March 2006
2006
Plain KM; Verma ND; Robinson C; Tran GT; Boyd RA; Nomura M; Hodgkinson SJ; Hall BM, 2006, 'Specific Suppressor T Cells That Inhibits Specific MLC Induced By Short-Term Culture Of Naïve CD4+CD25+ T Cells With Alloantigen And With IL-2, But Not With IL-4', in TSANZ - 24th Australian Academy of Science, TSANZ - 24th Australian Academy of Science, Canberra, pp. 45 - 45, presented at TSANZ - 24th Australian Academy of Science, Canberra, 29 March 2006 - 31 March 2006
2006
Tran GT; Carter N; Killingsworth MC; Nomura M; Hall BM; Hodgkinson SJ, 2006, 'The role of membrane attack complex (MAC) in complement component C6 deficient Lewis rat', in Journal of Neuroimmunology, Elsevier Science BV, Nagoya, JAPAN, Vol. 178, pp. 58 - 58, presented at 8th International Conference of Neuroimmunology, Nagoya, JAPAN, 15 October 2006 - 19 October 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241633100140&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2006
Hodgkinson SJ; Nomura M; Tran GT; Verma ND; Plain KM; Boyd RA; Hall BM, 2006, 'Interferon-Gamma (Ifn-¿×¿w¿nPromotes Survival Of Tolerance Mediating CD4+ T Cells From Rats Tolerant To A Cardiac Allograft', in TSANZ - 24th Australian Academy of Science, TSANZ - 24th Australian Academy of Science, Canberra, pp. 44 - 44, presented at TSANZ - 24th Australian Academy of Science, Canberra, 29 March 2006 - 31 March 2006
2006
Verma ND; Plain KM; Nomura M; Tran GT; Robinson C; Boyd RA; Hodgkinson SJ; Hall BM, 2006, 'CD4+CD25+ t suppressor cells induced by short-term culture with IL-2 or IL-4 and specific alloantigen have increased specific suppressive capacity both in vitro and in vivo', in Transplantation, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 612 - 612, presented at World Transplant Congress 2006, Boston, Massachusetts, 24 July 2006 - 27 July 2006
2006
Lam V; Laurence JA; Sharland A; Mccaughan GW; Hodgkinson SJ; Hall BM; Allen R; Bishop A, 2006, 'Induction of long-term cardiac allograft survival using anti-lymphocyte antibodies in the rat model', in Immunology and Cell Biology, Blackwell Publishing Asia, Australian Acad Sci, Canberra, AUSTRALIA, Vol. 84, pp. A27 - A27, presented at 24th Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, Australian Acad Sci, Canberra, AUSTRALIA, 29 March 2006 - 31 March 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237063000096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2006
Hodgkinson SJ; Carter N; Tran GT; Robinson CF; Hall BM, 2005, 'Mechanism of action of CD4+ CD25+ tolerant T cells in experimental allergic neuritis (EAN)', in Journal of the Peripheral Nervous System, Woodland Publications, Tuscany, ITALY, Vol. 10, pp. 34 - 34, presented at Meeting of the Peripheral Nerve Society, Tuscany, ITALY, 01 July 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230320000093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Tran GT; Carter N; Killingsworth MC; Nomura M; Hall BM; Hodgkinson SJ, 2005, 'The role of membrane attack complex (MAC) in complement component C6 deficient Lewis rat', in Journal of the Peripheral Nervous System, Woodland Publications, Tuscany, ITALY, Vol. 10, pp. 96 - 96, presented at Meeting of the Peripheral Nerve Society, Tuscany, ITALY, 01 July 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230320000262&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Wang C; Li J; Tran G; Hodgkinson SJ; Hall BM; McCaughan GW; Allen RDM; Bishop GA, 2005, 'Role of IL-4 in rat liver allograft rejection', in IMMUNOLOGY AND CELL BIOLOGY, BLACKWELL PUBLISHING, Canberra, AUSTRALIA, Vol. 83, pp. A11 - A11, presented at 23rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, Canberra, AUSTRALIA, 11 May 2005 - 13 May 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230636500048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2005
Tran GT; Verma ND; Plain KM; Robinson CF; Nomura M; Hall BM; Hodgkinson SJ, 2005, 'Cloning of rat IL-23 and its role in CD4(+) CD25(+) regulatory T cells function', in Immunology and Cell Biology, Blackwell Publishing Asia, Canberra, AUSTRALIA, Vol. 83, pp. A30 - A30, presented at 23rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, Canberra, AUSTRALIA, 11 May 2005 - 13 May 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230636500108&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Swain L; Booth D; Schibeci S; Pollard J; Hodgkinson SJ; Heard RN; Stewart GJ, 2005, 'CD127 and immuno-phenotypes in primary progressive multiple sclerosis', in Journal of the Neurological Sciences, Elsevier Science BV, Sydney, AUSTRALIA, Vol. 238, pp. S222 - S222, presented at 18th World Congress of Neurology, Sydney, AUSTRALIA, 05 November 2005 - 11 November 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088002103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Nomura M; Plain KM; Verma ND; Robinson C; Boyd RA; Hodgkinson SJ; Hall BM, 2005, 'Changing ratio of naïve CD4+, CD25- T cells and CD4+, CD 25+ T cells alter Responses in cardiac allograft rejection', in Immunology and Cell Biology, Blackwell Publishing Asia, Carlton, Victoria, Australia, Vol. 83, pp. A17 - A17, presented at 23rd Annual Scientific Meeting of the Transplantation Society of Australia and NZ, Canberra, 11 May 2005 - 13 May 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230636500068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Hall BM; Chen JC; Robinson C; He XY; Verma ND; Hodgkinson SJ, 2001, 'Therapy with monoclonal antibody to CD25 blocks function of CD4+, CD25+ T regulatory cells that maintain transplantation tolerance', in 19th Scientific Meeting The Transplantation society of Australia and New Zealand, 19th Scientific Meeting The Transplantation society of Australia and New Zealand, Canberra, pp. 3 - 3, presented at 19th Scientific Meeting The Transplantation society of Australia and New Zealand, Canberra, 04 April 2001 - 06 April 2001
2001
Hall BM; Chen JC; Robinson C; He XY; Plain KM; Verma ND; Hodgkinson SJ, 2001, 'Conditioned Dendritic cells as a temporal bridge between T Helper and cytotoxic cells', in Transplantation Proceedings, Elsevier Science Inc, Vol. 33, pp. 195 - 196, http://dx.doi.org/10.1016/S0041-1345(00)01972-2
2001
Robinson C; Chen JC; Carter N; Plain KM; He XY; Hodgkinson SJ; Hall BM, (ed.), 2001, 'Naive CD4+ CD25+ T cells partially inhibit naive CD4+ CD25- T cells in Alloimmune responses.', in 11th International Congress of Immunology, 11th International Congress of Immunology, Sweden, pp. 58 - 58, presented at 11th International Congress of Immunology, Sweden, 22 July 2001 - 27 July 2001
2001
Robinson C; Chen JC; He XY; Verma ND; Hodgkinson SJ; Hall BM, 2001, 'The role of CD25+, CD4+ and CD25-, CD4+ T cells in alloimmune responses', in 19th Scientific Meeting The Transplantation society of Australia and New Zealand, 19th Scientific Meeting The Transplantation society of Australia and New Zealand, Canberra, pp. 2 - 2, presented at 19th Scientific Meeting The Transplantation society of Australia and New Zealand, Canberra, 04 April 2001 - 06 April 2001
2001
Chen JC; Huoam C; Plain KM; He XY; Hodgkinson SJ; Hall BM, 2001, 'CD4+, CD25+ T cells as regulators of alloimmune responses', in Transplantation Proceedings, Elsevier Science Inc, Vol. 33, pp. 163 - 164, http://dx.doi.org/10.1016/S0041-1345(00)01956-4
2001
Chen JC; Robinson C; Plain KM; He XY; Verma ND; Hodgkinson SJ; Hall BM, 2001, 'Role of cytokines in maintenance of transplantation tolerance by CD4+, CD25+ TR cells', in 19th Scientific Meeting The Transplantation society of Australia and New Zealand, 19th Scientific Meeting The Transplantation society of Australia and New Zealand, Canberra, pp. 18 - 18, presented at 19th Scientific Meeting The Transplantation society of Australia and New Zealand, Canberra, 04 April 2001 - 06 April 2001
2001
Hall BM; Robinson C; Plain KM; Chen JC; Boyd RA; Carter N; Tran GT; He XY; Hodgkinson SJ, 2001, 'CD4+, CD25+ T cells induce and maintain tolerance to transplanted tissue', in ASI 2001 31st Annual Scientific Meeting, ASI 2001 31st Annual Scientific Meeting, Canberra, presented at ASI 2001 31st Annual Scientific Meeting, Canberra, 02 December 2001 - 06 December 2001
2001
Conference Presentations
add
Husin H; Wallace J; Malpas C; Sharmin S; Horakova D; Havrdova EK; Izquierdo G; Eichau S; Prat A; Girard M; Duquette P; Trojano M; Grammond P; Lugaresi A; Onofrj M; Ozakbas S; Butzkueven H; Sola P; Ferraro D; Alroughani R; Grand'Maison F; Terzi M; Lechner-Scott J; Boz C; Hupperts R; Shaygannejad V; Bergamaschi R; Pucci E; Van Pesch V; Hodgkinson S; McCombe P; Granella F; Slee M; Van Wijmeersch B; Karabudak R; Prevost J; Petersen T; Spitaleri D; Barnett M; Solaro C; Iuliano G; Verheul F; Ramo-Tello C; Turkoglu R; Fernandez Bolanos R; Butler E; Macdonell R; Soysal A; Betancur MM; Kalincik T, 2018, 'Determinants of MS re-activation after discontinuing therapies', Vol. 24, pp. 300 - 302, presented at 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, GERMANY, 10 October 2018 - 12 October 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000446861400464&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Ledingham D; El-Wahsh S; Cappelen-Smith C; Hodgkinson S; McDougall A; Maley M; Cordato D, 2018, 'PARADOXICAL REACTION IN TUBERCULOUS MENINGITIS: A TERTIARY REFERRAL HOSPITAL RETROSPECTIVE EXPERIENCE OF CONCOMITANT IMMUNOSUPPRESSION THERAPY', Vol. 89, pp. E8 - E8, presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), Darwin, AUSTRALIA, 29 May 2018 - 01 June 2018, http://dx.doi.org/10.1136/jnnp-2018-ANZAN.17
2018
Conference Papers
add
Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM, 2017, 'Human CD4+CD25+CD127loFOXP3+Treg Activation by IL-4 and Alloantigen Induces Activated Treg that do not Express CD45RA and Express the IL-5 Receptor Alpha (CD125)', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Victoria, CANADA, pp. S7 - S7, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, Victoria, CANADA, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520300.20897.2c
2017
Kalincik T; Spelman T; Jokubaitis V; Horakova D; Havrdova E; Izquierdo G; Prat A; Girard M; Duquette P; Lugaresi A; Grammond P; Alroughani R; Lechner-Scott J; Prevost J; Terzi M; Grand'Maison F; Boz C; Trojano M; Van Wijmeersch B; Pucci E; Granella F; Turkoglu R; Sola P; Ferraro D; McCombe P; Solaro C; Van Pesch V; Ozakbas S; Slee M; Spitaleri D; Sanchez-Menoyo JL; Ampapa R; Hodgkinson S; Karabudak R; Vucic S; Butzkueven H, 2017, 'Effectiveness of fingolimod, dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis: a comparative longitudinal study', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Paris, FRANCE, pp. 325 - 327, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, FRANCE, 25 October 2017 - 28 October 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730202066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Kister I; Spelman T; Patti F; Duquette P; Trojano M; Izquierdo G; Lugaresi A; Grammond P; Sola P; Ferraro D; Grand'Maison F; Alroughani R; Terzi M; Boz C; Hupperts R; Lechner-Scott J; Kapos L; Pucci E; Hodgkinson S; Solaro C; Butzkueven H, 2017, 'Predictors of relapses and disability progression after stopping disease-modifying therapies for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Paris, FRANCE, pp. 356 - 357, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, FRANCE, 25 October 2017 - 28 October 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730202114&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Jokubaitis VG; Havrdova E; Horakova D; Izquierdo G; Kalincik T; van der Walt A; Nguyen A-L; Terzi M; Alroughani R; Duquette P; Girard M; Prat A; Boz C; Sola P; Lugaresi A; Lechner-Scott J; Barnett M; Grand'Maison F; Grammond P; Ramo C; Turkoglu R; McCombe P; Hupperts R; Bolanos RF; Pucci E; Trojano M; Granella F; Spitaleri D; Van Pesch V; Soysal A; Oreja-Guevara C; Verheul F; Vucic S; Hodgkinson S; Slee M; Ampapa R; Prevost J; Menoyo JLS; Skibina O; Iuliano G; Solaro C; Olascoaga J; Shaw C; Madsen K; Naidoo K; Hyde R; Butzkueven H, 2017, 'Pregnancy incidence and therapy exposure in relapsing forms of MS: a 12-year retrospective multicentre analysis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Paris, FRANCE, pp. 130 - 132, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, FRANCE, 25 October 2017 - 28 October 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730200200&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Haartsen J; Spelman T; Baker J; Agland S; Lechner-Scott J; Burke T; Vucic S; Rath L; Skibina O; Toubia M; Slee M; Taylor B; Mac Gregor S; Oconnell AM; Barnett M; Baker S; Sharma M; Hodgkinson S; Walters S; Kermode A; Hayes W; Butler E; Sheuy N; Shaw C; Portley R; Hardy T; Tan IL; Butzkueven H, 2017, 'MS FIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Paris, FRANCE, pp. 403 - 404, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, FRANCE, 25 October 2017 - 28 October 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730202177&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Firtko A; Thomas P; Hodgkinson S, 2017, 'Effect of Post-Acute Nurse Led Stroke Clinic (PASC) on readmissions rates for TIA/Stroke', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, pp. 10 - 11, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408220500026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2017
Spelman T; Schulz M; Arora B; Chung E; Juneja P; Walker R; Verhaeghe S; Butzkueven H; Hodgkinson S; Lechner-Scott J; McCombe P; Slee M; Butler E; Barnett M; Skibina O; Vucic S; Macdonell R; Shuey N; Taylor B; Broadley S, 2017, 'Persistence to fingolimod compared with other disease modifying therapies in the Australian real-world setting using the MS base registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Paris, FRANCE, pp. 631 - 631, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, FRANCE, 25 October 2017 - 28 October 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730204050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2017
Kalincik T; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Lechner-Scott J; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Solaro C; Grand'Maison F; Hupperts R; Prevost J; Sola P; Ferraro D; Terzi M; Butler E; Slee M; Kermode A; Fabis-Pedrini M; McCombe P; Barnett M; Shaw C; Hodgkinson S; Butzkueven H, 2017, 'Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Paris, FRANCE, pp. 596 - 597, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, FRANCE, 25 October 2017 - 28 October 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730203308&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Jokubaitis V; Ai-Lan N; Kalincik T; van der Walt A; Lechner-Scott J; Barnett M; McCombe P; Vucic S; Hodgkinson S; Slee M; Skibina O; Shaw C; Butzkueven H, 2017, 'Pregnancy incidence, therapy exposure and post-partum relapse risk: a 12-year retrospective multicentre analysis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, MS Res Australia, Sydney, AUSTRALIA, pp. NP4 - NP4, presented at Progress in MS Research Conference, MS Res Australia, Sydney, AUSTRALIA, 11 October 2017 - 13 October 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2017
Hall BM; Hall RM; Verma ND; Robinson CM; Wilcox P; Tran GT; Wang C; Sharland A; Hodgkinson SJ, 2017, 'Interleukin 5 (IL-5) Treatment Prevents Chronic Allograft Rejection by Promoting IL-5 Receptor Expressing CD4+CD25+T Regulatory Ts2 Cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Victoria, CANADA, pp. S43 - S43, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, Victoria, CANADA, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520363.08810.76
2017
Wilcox P; Robinson CM; Verma ND; Nomura M; Tran GT; Carter N; Boyd R; Hodgkinson SJ; Hall BM, 2017, 'CD8 Expression Increases Suppressive Ability of CD4+CD25+Treg and is a Marker of Antigen-Specificity', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Victoria, CANADA, pp. S37 - S37, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, Victoria, CANADA, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520351.47820.c8
2017
Hall BM; Robinson CM; Wilcox P; Verma ND; Tran GT; Carter N; Boyd RA; Hodgkinson SJ, 2016, 'Recently alloactivated CD4+CD8-CD25+Treg express CD8 and are the antigen-specific Treg', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, pp. S120 - S120, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953200190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Verma N; Robinson CM; Tran GT; Hall RM; Wilcox P; Hodgkinson SJ; Hall BM, 2016, 'Activation of Human CD4+CD25+CD127loFOXP3+Treg by IL-4 and alloantigen induces activated Treg that do not express CD45RA and express the IL-5 receptor alpha (CD125)', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, pp. S460 - S460, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953201100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2016
Hodgkinson SJ; Hall BM; Hall RM; Robinson CM; Wilcox P; Tran GT; Wang C; Sharland A, 2016, 'Interleukin-5 therapy prevents chronic allograft rejection by induction of antigen specific CD4+CD25+T regulatory cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, pp. S65 - S65, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953200108&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2016
Jokubaitis VG; Li V; Kalincik T; Izquierdo G; Hodgkinson S; Alroughani R; Lechner-Scott J; Lugaresi A; Duquette P; Girard M; Barnett M; Grand'Maison F; Trojano M; Slee M; Giuliani G; Shaw C; Boz C; Haartsen J; Liew D; Butzkueven H, 2013, 'Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Copenhagen, DENMARK, pp. 55 - 56, presented at 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, DENMARK, 02 October 2013 - 05 October 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000328751400086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Cordato DJ; Thomas PR; Darshan G; Sanjeev T; Worthington JM; McDougall AJ; Hodgkinson SJ; Ibrahim HY; Griffith NC; Cappelen-Smith C; Beran RG, 2010, 'Decreasing Presentations of Seizures to Emergency Departments in a Large Australian Population', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, Toronto, CANADA, pp. A258 - A258, presented at 62nd Annual Meeting of the American-Academy-of-Neurology, Toronto, CANADA, 10 April 2010 - 17 April 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000275274001259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2010
LINDSEY JW; HODGKINSON S; MEHTA R; SIEGEL RC; MITCHELL DJ; LIM M; PIERCY C; TRAM T; DORFMAN L; ENZMANN D; STEINMAN L, 1994, 'PHASE-1 CLINICAL-TRIAL OF CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY IN MULTIPLE-SCLEROSIS', in NEUROLOGY, LITTLE BROWN CO, SAN DIEGO, CA, pp. 413 - 419, presented at 44th Annual Meeting of the American-Academy-of-Neurology, SAN DIEGO, CA, 01 May 1992, http://dx.doi.org/10.1212/WNL.44.3_Part_1.413
1994
LINDSEY JW; HODGKINSON S; MEHTA R; ENZMANN D; SANDERS M; STEINMAN L, 1993, 'PHASE-I STUDY OF REPEATED TREATMENT WITH CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY IN MULTIPLE-SCLEROSIS', in NEUROLOGY, LIPPINCOTT-RAVEN PUBL, pp. A280 - A281, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KY35600489&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
1993
Patents
add
He XY; Hall BM; Hodgkinson SJ, 2000, Methods of inducing Immune Tolerance., Patent No.
2000